[Practical experience of endotelon application in patients with cervix uteri cancer after extended panhysterectomy].
Application of endotelon in early period after extended panhysterectomy in patients with cervix uteri cancer of I-II stages promotes reduction of the occurrence frequency of retroperitoneal lymphatic cyst and lymphostasis in parametrium and lower extremities.
Dolyk
S S
SS
D044946:Biflavonoids / Q000627:therapeutic use*; D002392:Catechin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000145:classification* / Q000379:methods*; D009367:Neoplasm Staging; D011184:Postoperative Period; D044945:Proanthocyanidins / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000601:surgery*
D044946:Biflavonoids; D044945:Proanthocyanidins; C479585:procyanidol oligomer; D002392:Catechin
Praktychnyĭ dosvid zastosuvannia endotelonu u khvorykh na rak shyĭky matky pislia rozshyrenoï panhisterektomiï.